Site Search

ALBANY, NY – A coalition of more than 65 patient and provider groups, cancer centers, and other public health organizations delivered a letter to state legislative leaders in support of legislation that would require insurance plans to cover ... stool-based screening test, it should be considered as the next step in the preventive screening process and therefore should be covered by health insurers with no patient out-of-pocket cost. ACS CAN is calling on state leaders to include S906-B sponsored by Senators Sanders and Kennedy ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...

... and clinical trial across Minnesota, and what researchers need to ensure all patients can equitably access the latest innovations in cancer care and treatment. Every new breakthrough in freeing the world from the pain and suffering of cancer - from new cures to innovative ways to ... prevent and treat the disease - have one thing in common; the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.  This virtual event will discuss Community Oncology Research Programs (NCORP), the impact that NIH and ... , Principal Investigator, Metro-Minnesota Community Oncology Research Consortium Bret E. Friday, Ph.D., M.D. , Principal Investigator, Essentia Health Community NCORP Preston D. Steen, M.D. , Principal Investigator, Sanford Community Cancer Program NCORP Kelly Leibold , ACS CAN Minnesota ...

Sacramento, Calif. –  The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which was introduced by Senator ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “The advances in cancer treatment that have come ... from being able to tailor approaches to a person’s individual condition are critical for winning the fight against cancer and helping reduce health disparities,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the ...

... life enhancing tool,” said Michael, from Tucson. “Biomarker testing and precision medicine are helping extend and save lives by tailoring care and treatment to a person’s individual disease,” said Brian Hummell, government relations director for the American Cancer Society Cancer ... of cancer clinical trials that involve biomarkers has grown significantly.” Despite its benefits and increasingly important role in cancer care, access to biomarker testing has not kept pace with the rate of innovation and advancements in treatment. One significant barrier for patients is lack of coverage by private health insurance and Medicaid programs for appropriate testing. Currently, communities that have been under-resourced, including communities of ...